Sol-gel technologies stock
WebJan 27, 2024 · Sol-Gel broadens its pipeline with this new chemical entity, designated as investigational compound SGT-610, which has the potential to be the first-ever drug for treatment of Gorlin syndrome. Sol-Gel expects the transaction to close on or about January 30, 2024, subject to the satisfaction of customary closing conditions. WebFind real-time SLGL - Sol Gel Technologies Ltd stock quotes, company profile, news and forecasts from CNN Business.
Sol-gel technologies stock
Did you know?
WebApr 12, 2024 · H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Sol-Gel Technologies ( SLGL – Research Report) today and set a price target of $19.00. The … WebDec 1, 2024 · Sol-Gel Technologies (SLGL) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
WebMar 31, 2024 · Complete Sol-Gel Technologies Ltd. stock information by Barron's. View real-time SLGL stock price and news, along with industry-best analysis. WebBased on 2 Wall Street analysts offering 12 month price targets for Sol-Gel Technologies in the last 3 months. The average price target is $14.50 with a high forecast of $19.00 and a …
WebNov 4, 2024 · NESS ZIONA, Israel, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (Nasdaq: SLGL), (“Sol-Gel”), a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced a new … WebApr 6, 2024 · Sol Gel Technologies Ltd (SLGL) stock is trading at $3.75 as of 2:46 PM on Thursday, Apr 6, an increase of $0.09, or 2.46% from the previous closing price of $3.66. The stock has traded between $3.65 and $3.85 so far today. Volume today is below average. So far 5,429 shares have traded compared to average volume of 18,788 shares.
WebSector Industry Market Cap Revenue; Medical: Medical - Generic Drugs: $0.087B: $0.004B: Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.
WebNESS ZIONA, Israel, March 10, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company with two innovative dermatology products that were launched in the U.S. and an innovative pipeline, today announced financial results for the full year ended December 31, 2024 and provided a corporate update. Mar 10, 2024. how to shrink a pdf for printingWebMar 4, 2024 · SLGL stock forecast for 2024 – 2027. Last updated: March 4, 2024. SLGL. Sol-Gel Technologies Ltd. 4.21 D 7.27% (0.33) Are you interested in Sol-Gel Technologies Ltd. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the SLGL stock price in 2024-2027. Is SLGL a good long term stock? notts soccerwayWebMar 17, 2024 · The latest price target for Sol-Gel Technologies ( NASDAQ: SLGL) was reported by Raymond James on Tuesday, March 14, 2024. The analyst firm set a price target for 10.00 expecting SLGL to rise to ... notts smash repairs warrawongWebYou can buy and sell Sol-Gel Technologies (SLGL) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. ... notts speed camerasWebSol Gel Technologies (SLGL) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Support: 888-992-3836 Home NewsWire Subscriptions ... Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. notts showWebThe Sol-Gel Technologies stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, … notts shooting and fishingWeb1 day ago · 3 Generic Drug Stocks to Watch Amid Inflation Pressures 12/07/22-9:52AM EST Zacks. Other News for SLGL H.C. Wainwright Keeps Their Buy Rating on Sol-Gel Technologies (SLGL) 04/12/23-5:16AM EST ... notts sport childsplay